Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: ProgModule: A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response

Fig. 3

Comparing the prognostic ability of modules versus individual genes. (A) Comparing the prognostic ability of candidate modules versus individual genes in BLCA; (B) Kaplan-Meier survival analysis of OS comparing the M15-Mutant and WT groups; (C) Kaplan-Meier survival analysis of OS comparing the TFE3-Mutant and WT groups; (D) Kaplan-Meier survival analysis of OS comparing the M16-Mutant and WT groups; (E) Kaplan-Meier survival analysis of OS comparing the BCAR1-Mutant and WT groups; (F) Kaplan-Meier survival curve of risk model in TCGA-BLCA; (G) The ROC curve of risk model to predict patient OS in TCGA-BLCA; (H) The Kaplan-Meier survival curve of risk model in ICGC-BLCA; (I) The ROC curve of risk model to predict patient OS in ICGC-BLCA

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us